QSAM Biosciences RSI
¿Qué es el RSI de QSAM Biosciences?
El RSI de QSAM Biosciences, Inc. es 68.60
¿Cuál es la definición de RSI?
El índice de fortaleza relativa (RSI 14) es un indicador de impulso que compara la magnitud de las ganancias y pérdidas durante un período de tiempo específico para medir la velocidad y el cambio de los movimientos de precios de un valor.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI de compañías en Sector Health Care en OTC en comparadas con QSAM Biosciences
¿Qué hace QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Empresas con rsi similar a QSAM Biosciences
- Real Estate & E-Comm Split tiene RSI de 68.58
- Templeton Global Growth Fund tiene RSI de 68.58
- Dolly Varden Silver tiene RSI de 68.58
- Majestic Gold tiene RSI de 68.58
- TCW Strategic Income Fund Inc tiene RSI de 68.59
- LHN tiene RSI de 68.59
- QSAM Biosciences tiene RSI de 68.60
- SK Telecom Co Ltd tiene RSI de 68.61
- GFL tiene RSI de 68.61
- EPR Properties tiene RSI de 68.61
- Alembic Pharmaceuticals tiene RSI de 68.61
- Marico tiene RSI de 68.62
- Calnex Solutions Plc tiene RSI de 68.63